Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, Nicotinic | 21 | 2016 | 495 | 1.830 |
Why?
|
Nicotinic Agonists | 13 | 2016 | 265 | 1.250 |
Why?
|
Behavior, Animal | 18 | 2022 | 1878 | 0.910 |
Why?
|
Motor Activity | 13 | 2019 | 2715 | 0.770 |
Why?
|
Antidepressive Agents | 12 | 2016 | 2897 | 0.720 |
Why?
|
Azetidines | 6 | 2014 | 142 | 0.700 |
Why?
|
Nicotine | 8 | 2008 | 680 | 0.530 |
Why?
|
Neurotransmitter Uptake Inhibitors | 2 | 2010 | 36 | 0.450 |
Why?
|
Amitriptyline | 2 | 2004 | 112 | 0.450 |
Why?
|
Rodentia | 1 | 2014 | 262 | 0.430 |
Why?
|
Quinoxalines | 2 | 2011 | 296 | 0.400 |
Why?
|
Benzazepines | 2 | 2011 | 310 | 0.400 |
Why?
|
Fear | 11 | 2024 | 1477 | 0.400 |
Why?
|
Antidepressive Agents, Tricyclic | 2 | 2004 | 432 | 0.390 |
Why?
|
Gamma Rays | 2 | 2024 | 318 | 0.390 |
Why?
|
Glycogen Synthase Kinase 3 | 2 | 2011 | 411 | 0.390 |
Why?
|
CLOCK Proteins | 1 | 2011 | 86 | 0.370 |
Why?
|
Iron Radioisotopes | 2 | 2021 | 19 | 0.370 |
Why?
|
Alzheimer Disease | 9 | 2024 | 8601 | 0.360 |
Why?
|
Helplessness, Learned | 4 | 2004 | 28 | 0.330 |
Why?
|
Cyclopropanes | 3 | 2017 | 432 | 0.320 |
Why?
|
Pyridines | 5 | 2011 | 2875 | 0.320 |
Why?
|
Sex Characteristics | 6 | 2024 | 2639 | 0.310 |
Why?
|
Mice, Inbred C57BL | 24 | 2024 | 22174 | 0.310 |
Why?
|
Alzheimer Vaccines | 2 | 2020 | 25 | 0.300 |
Why?
|
Locomotion | 1 | 2010 | 388 | 0.300 |
Why?
|
Presenilin-1 | 3 | 2021 | 660 | 0.280 |
Why?
|
Mice | 48 | 2024 | 81539 | 0.280 |
Why?
|
Hippocampus | 7 | 2023 | 3766 | 0.280 |
Why?
|
Drug Discovery | 1 | 2014 | 1051 | 0.270 |
Why?
|
Swimming | 4 | 2011 | 208 | 0.270 |
Why?
|
Antipsychotic Agents | 4 | 2017 | 3067 | 0.260 |
Why?
|
Animals | 67 | 2024 | 168475 | 0.260 |
Why?
|
Morphine | 4 | 2001 | 657 | 0.250 |
Why?
|
Mice, Knockout | 21 | 2024 | 14417 | 0.240 |
Why?
|
Anxiety | 4 | 2019 | 4573 | 0.240 |
Why?
|
Mice, Transgenic | 10 | 2024 | 9542 | 0.240 |
Why?
|
Complement C3 | 2 | 2017 | 435 | 0.230 |
Why?
|
Cosmic Radiation | 1 | 2024 | 24 | 0.230 |
Why?
|
Plaque, Amyloid | 3 | 2021 | 760 | 0.230 |
Why?
|
Disease Models, Animal | 10 | 2024 | 18255 | 0.230 |
Why?
|
Serotonin 5-HT2 Receptor Agonists | 2 | 2017 | 31 | 0.230 |
Why?
|
Hindlimb Suspension | 4 | 2010 | 75 | 0.220 |
Why?
|
Pyrrolidonecarboxylic Acid | 3 | 2021 | 65 | 0.220 |
Why?
|
Benzhydryl Compounds | 1 | 2010 | 916 | 0.210 |
Why?
|
Wakefulness | 1 | 2010 | 1265 | 0.210 |
Why?
|
Methylamines | 2 | 2017 | 136 | 0.210 |
Why?
|
Cocaine | 4 | 2010 | 958 | 0.200 |
Why?
|
Structure-Activity Relationship | 9 | 2017 | 3076 | 0.200 |
Why?
|
Central Nervous System Stimulants | 2 | 2010 | 1177 | 0.200 |
Why?
|
Islet Amyloid Polypeptide | 1 | 2021 | 42 | 0.200 |
Why?
|
Piperidines | 1 | 2010 | 1656 | 0.200 |
Why?
|
Amyloid beta-Peptides | 6 | 2024 | 3839 | 0.190 |
Why?
|
Conditioning, Classical | 5 | 2005 | 368 | 0.190 |
Why?
|
alpha-Synuclein | 2 | 2018 | 750 | 0.190 |
Why?
|
RGS Proteins | 2 | 2013 | 74 | 0.190 |
Why?
|
Dose-Response Relationship, Drug | 6 | 2011 | 10766 | 0.180 |
Why?
|
Dementia, Vascular | 1 | 2021 | 122 | 0.170 |
Why?
|
Isoxazoles | 2 | 2012 | 232 | 0.170 |
Why?
|
Mice, Inbred BALB C | 7 | 2019 | 6214 | 0.170 |
Why?
|
Maze Learning | 5 | 2024 | 483 | 0.170 |
Why?
|
Nicotinic Antagonists | 4 | 2014 | 94 | 0.170 |
Why?
|
Socialization | 1 | 2019 | 87 | 0.170 |
Why?
|
Drug Partial Agonism | 4 | 2012 | 24 | 0.160 |
Why?
|
Brain | 12 | 2024 | 27121 | 0.160 |
Why?
|
Anti-Anxiety Agents | 1 | 2021 | 397 | 0.160 |
Why?
|
Ligands | 7 | 2017 | 3272 | 0.160 |
Why?
|
tau Proteins | 3 | 2021 | 2095 | 0.160 |
Why?
|
Brain Chemistry | 1 | 2002 | 960 | 0.160 |
Why?
|
Electroshock | 7 | 2005 | 121 | 0.150 |
Why?
|
Rats | 16 | 2021 | 23741 | 0.150 |
Why?
|
Freezing Reaction, Cataleptic | 2 | 2016 | 41 | 0.150 |
Why?
|
Rats, Sprague-Dawley | 11 | 2010 | 8181 | 0.150 |
Why?
|
Urination | 1 | 2019 | 203 | 0.150 |
Why?
|
Association Learning | 3 | 2006 | 222 | 0.150 |
Why?
|
Physical Conditioning, Animal | 1 | 2021 | 365 | 0.150 |
Why?
|
Fibronectins | 1 | 2021 | 723 | 0.150 |
Why?
|
Receptor, Serotonin, 5-HT2C | 1 | 2017 | 42 | 0.150 |
Why?
|
Larva | 2 | 2016 | 508 | 0.150 |
Why?
|
Receptors, GABA-A | 1 | 2022 | 623 | 0.150 |
Why?
|
Hormones | 1 | 2021 | 869 | 0.140 |
Why?
|
Reflex | 1 | 2019 | 376 | 0.140 |
Why?
|
Immunization, Passive | 2 | 2020 | 616 | 0.140 |
Why?
|
Neurons | 7 | 2018 | 9463 | 0.140 |
Why?
|
Dopamine Uptake Inhibitors | 2 | 2010 | 297 | 0.140 |
Why?
|
Seizures | 2 | 2022 | 2957 | 0.140 |
Why?
|
Memory | 3 | 2024 | 2193 | 0.140 |
Why?
|
Space Flight | 1 | 2019 | 215 | 0.140 |
Why?
|
Depression | 5 | 2014 | 8126 | 0.130 |
Why?
|
Bipolar Disorder | 2 | 2011 | 5092 | 0.130 |
Why?
|
Tobacco Use Disorder | 1 | 2002 | 703 | 0.130 |
Why?
|
Escape Reaction | 1 | 2016 | 57 | 0.130 |
Why?
|
Receptors, Adrenergic, beta-2 | 1 | 2017 | 215 | 0.130 |
Why?
|
Benzylamines | 1 | 2017 | 247 | 0.130 |
Why?
|
Receptors, sigma | 1 | 2016 | 45 | 0.130 |
Why?
|
Mecamylamine | 2 | 2006 | 27 | 0.130 |
Why?
|
Molecular Structure | 4 | 2016 | 1880 | 0.130 |
Why?
|
Amyloid beta-Protein Precursor | 2 | 2021 | 1111 | 0.130 |
Why?
|
Antibodies, Monoclonal | 3 | 2020 | 9177 | 0.130 |
Why?
|
Microglia | 2 | 2022 | 1362 | 0.130 |
Why?
|
Parkinsonian Disorders | 1 | 2018 | 284 | 0.130 |
Why?
|
Neurosciences | 1 | 2019 | 367 | 0.120 |
Why?
|
Synaptosomes | 2 | 2015 | 116 | 0.120 |
Why?
|
Apyrase | 1 | 2017 | 373 | 0.120 |
Why?
|
Cognition | 4 | 2021 | 6992 | 0.120 |
Why?
|
Stress, Physiological | 1 | 2002 | 1403 | 0.120 |
Why?
|
Stereoisomerism | 5 | 2017 | 614 | 0.120 |
Why?
|
Zebrafish | 2 | 2016 | 3008 | 0.120 |
Why?
|
Nerve Degeneration | 2 | 2017 | 748 | 0.120 |
Why?
|
Dopamine | 3 | 2010 | 1607 | 0.110 |
Why?
|
Pain Threshold | 3 | 1996 | 604 | 0.110 |
Why?
|
Neuroglia | 1 | 2020 | 956 | 0.110 |
Why?
|
Substance-Related Disorders | 2 | 2010 | 4420 | 0.110 |
Why?
|
Organ Transplantation | 1 | 2023 | 1157 | 0.110 |
Why?
|
Avoidance Learning | 4 | 2005 | 248 | 0.110 |
Why?
|
Social Behavior | 1 | 2019 | 1135 | 0.110 |
Why?
|
Analgesia | 1 | 1997 | 461 | 0.100 |
Why?
|
Adenosine | 1 | 2017 | 808 | 0.100 |
Why?
|
Aging | 5 | 2023 | 8710 | 0.100 |
Why?
|
Male | 39 | 2024 | 360846 | 0.100 |
Why?
|
Amygdala | 1 | 2019 | 1354 | 0.100 |
Why?
|
Analysis of Variance | 3 | 2008 | 6228 | 0.090 |
Why?
|
Heart | 1 | 2024 | 4404 | 0.090 |
Why?
|
Adenosine Triphosphate | 1 | 2017 | 1989 | 0.090 |
Why?
|
Mice, Inbred A | 1 | 2010 | 246 | 0.090 |
Why?
|
Aza Compounds | 1 | 2010 | 34 | 0.090 |
Why?
|
Radioligand Assay | 4 | 2012 | 366 | 0.090 |
Why?
|
Small Molecule Libraries | 1 | 2016 | 733 | 0.090 |
Why?
|
Mice, Mutant Strains | 2 | 2011 | 1749 | 0.090 |
Why?
|
Depressive Disorder | 1 | 2003 | 3728 | 0.090 |
Why?
|
Nociceptors | 1 | 1994 | 461 | 0.090 |
Why?
|
Biogenic Monoamines | 1 | 2010 | 50 | 0.090 |
Why?
|
Tranylcypromine | 1 | 2009 | 30 | 0.080 |
Why?
|
Dose-Response Relationship, Radiation | 2 | 2023 | 882 | 0.080 |
Why?
|
Adrenergic Uptake Inhibitors | 1 | 2010 | 186 | 0.080 |
Why?
|
Chromosome Mapping | 1 | 1997 | 4615 | 0.080 |
Why?
|
Kidney | 1 | 2024 | 7048 | 0.080 |
Why?
|
Substance Withdrawal Syndrome | 3 | 2010 | 625 | 0.080 |
Why?
|
Cell Proliferation | 1 | 2004 | 10451 | 0.080 |
Why?
|
Time Factors | 5 | 2021 | 39969 | 0.080 |
Why?
|
GTP-Binding Proteins | 1 | 2013 | 951 | 0.080 |
Why?
|
Pyrrolidines | 1 | 2010 | 338 | 0.080 |
Why?
|
Transcription, Genetic | 2 | 2019 | 7593 | 0.080 |
Why?
|
Mitochondria | 1 | 2022 | 3624 | 0.080 |
Why?
|
Norepinephrine | 1 | 2010 | 897 | 0.070 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 1 | 2010 | 415 | 0.070 |
Why?
|
Gene Expression Regulation | 2 | 2017 | 11904 | 0.070 |
Why?
|
Dopamine and cAMP-Regulated Phosphoprotein 32 | 1 | 2006 | 29 | 0.070 |
Why?
|
Genotype | 1 | 2021 | 12990 | 0.070 |
Why?
|
Aminopyridines | 1 | 2010 | 573 | 0.070 |
Why?
|
Cerebral Cortex | 3 | 2017 | 5779 | 0.070 |
Why?
|
Protein Binding | 4 | 2012 | 9353 | 0.070 |
Why?
|
Neuralgia | 1 | 2013 | 615 | 0.070 |
Why?
|
Nucleus Accumbens | 3 | 2006 | 366 | 0.070 |
Why?
|
Sex Factors | 4 | 2024 | 10554 | 0.060 |
Why?
|
Cognition Disorders | 2 | 2021 | 3980 | 0.060 |
Why?
|
Serotonin | 1 | 2010 | 1041 | 0.060 |
Why?
|
Random Allocation | 1 | 2010 | 2395 | 0.060 |
Why?
|
Hypothalamus | 1 | 2010 | 999 | 0.060 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2010 | 1334 | 0.060 |
Why?
|
Nortriptyline | 1 | 2004 | 79 | 0.060 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2006 | 484 | 0.060 |
Why?
|
Bromodeoxyuridine | 1 | 2004 | 311 | 0.060 |
Why?
|
Corpus Striatum | 1 | 2010 | 1235 | 0.060 |
Why?
|
Lithium | 1 | 2007 | 596 | 0.060 |
Why?
|
Recreation | 1 | 2004 | 125 | 0.060 |
Why?
|
Immunotherapy | 2 | 2021 | 4652 | 0.060 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2005 | 233 | 0.060 |
Why?
|
Mice, Inbred ICR | 2 | 2003 | 364 | 0.060 |
Why?
|
Antiparkinson Agents | 2 | 2018 | 184 | 0.060 |
Why?
|
Antimanic Agents | 1 | 2007 | 520 | 0.050 |
Why?
|
Models, Biological | 1 | 2019 | 9469 | 0.050 |
Why?
|
Binding, Competitive | 3 | 2011 | 1141 | 0.050 |
Why?
|
Parkinson Disease | 1 | 2017 | 2877 | 0.050 |
Why?
|
Asphyxia | 1 | 2003 | 60 | 0.050 |
Why?
|
Neurons, Efferent | 1 | 2003 | 81 | 0.050 |
Why?
|
Pain Measurement | 3 | 2003 | 3551 | 0.050 |
Why?
|
Neuronal Plasticity | 2 | 2015 | 1436 | 0.050 |
Why?
|
Area Postrema | 1 | 2021 | 6 | 0.050 |
Why?
|
Electrical Synapses | 1 | 2022 | 18 | 0.050 |
Why?
|
Drug Design | 1 | 2007 | 1048 | 0.050 |
Why?
|
Oncogene Protein v-akt | 1 | 2022 | 129 | 0.050 |
Why?
|
Hypertension | 1 | 2022 | 8540 | 0.050 |
Why?
|
Microsomes, Liver | 2 | 2012 | 173 | 0.050 |
Why?
|
Circadian Rhythm | 2 | 2011 | 2576 | 0.050 |
Why?
|
Obesity | 1 | 2024 | 12947 | 0.050 |
Why?
|
Gliosis | 2 | 2017 | 245 | 0.050 |
Why?
|
Arousal | 2 | 2000 | 1166 | 0.050 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2009 | 1252 | 0.050 |
Why?
|
Data Interpretation, Statistical | 1 | 2011 | 2691 | 0.050 |
Why?
|
Female | 21 | 2024 | 392705 | 0.050 |
Why?
|
Gambling | 1 | 2004 | 258 | 0.050 |
Why?
|
Neuropeptides | 1 | 2006 | 944 | 0.050 |
Why?
|
Nerve Tissue Proteins | 2 | 2005 | 4415 | 0.040 |
Why?
|
Synaptic Vesicles | 1 | 2002 | 190 | 0.040 |
Why?
|
Genetics, Behavioral | 1 | 2000 | 53 | 0.040 |
Why?
|
Cell Count | 1 | 2004 | 1835 | 0.040 |
Why?
|
Hybridization, Genetic | 1 | 2000 | 103 | 0.040 |
Why?
|
Drug Administration Schedule | 1 | 2008 | 4853 | 0.040 |
Why?
|
Drug Interactions | 1 | 2004 | 1416 | 0.040 |
Why?
|
Cytoskeleton | 1 | 2005 | 1170 | 0.040 |
Why?
|
Prefrontal Cortex | 1 | 2010 | 2220 | 0.040 |
Why?
|
Habituation, Psychophysiologic | 1 | 2000 | 147 | 0.040 |
Why?
|
Carbon Dioxide | 1 | 2003 | 1147 | 0.040 |
Why?
|
Conditioning, Operant | 1 | 2000 | 310 | 0.040 |
Why?
|
Mice, Inbred DBA | 1 | 2019 | 621 | 0.040 |
Why?
|
Mice, Inbred Strains | 2 | 2000 | 1762 | 0.040 |
Why?
|
Exploratory Behavior | 2 | 2015 | 279 | 0.040 |
Why?
|
Neurotransmitter Agents | 1 | 2002 | 665 | 0.040 |
Why?
|
Adrenergic beta-1 Receptor Agonists | 1 | 2017 | 14 | 0.040 |
Why?
|
Receptor, Serotonin, 5-HT2B | 1 | 2017 | 6 | 0.040 |
Why?
|
Levodopa | 1 | 2018 | 221 | 0.040 |
Why?
|
Cocaine-Related Disorders | 1 | 2001 | 461 | 0.040 |
Why?
|
Memory Disorders | 1 | 2005 | 1199 | 0.040 |
Why?
|
Endocytosis | 1 | 2002 | 957 | 0.040 |
Why?
|
Urinary Bladder, Overactive | 1 | 2019 | 115 | 0.040 |
Why?
|
Protons | 1 | 2023 | 1116 | 0.040 |
Why?
|
Self Administration | 2 | 2010 | 390 | 0.040 |
Why?
|
Actins | 1 | 2005 | 2050 | 0.040 |
Why?
|
Hyperkinesis | 1 | 2017 | 89 | 0.040 |
Why?
|
Behavior | 1 | 2000 | 541 | 0.040 |
Why?
|
Lod Score | 1 | 1997 | 600 | 0.040 |
Why?
|
Signal Transduction | 5 | 2022 | 23447 | 0.040 |
Why?
|
Synapses | 2 | 2017 | 1769 | 0.030 |
Why?
|
Thalamus | 1 | 2003 | 1047 | 0.030 |
Why?
|
Humans | 22 | 2023 | 761596 | 0.030 |
Why?
|
Albuterol | 1 | 2017 | 213 | 0.030 |
Why?
|
Mice, Inbred C3H | 1 | 1997 | 915 | 0.030 |
Why?
|
Molecular Biology | 1 | 2000 | 576 | 0.030 |
Why?
|
Blood Proteins | 2 | 2012 | 1173 | 0.030 |
Why?
|
Norway | 1 | 2017 | 499 | 0.030 |
Why?
|
Protein Conformation | 2 | 2018 | 3968 | 0.030 |
Why?
|
Phagocytosis | 1 | 2022 | 1528 | 0.030 |
Why?
|
Propranolol | 1 | 2017 | 489 | 0.030 |
Why?
|
Synapsins | 1 | 2015 | 43 | 0.030 |
Why?
|
Substantia Nigra | 1 | 2017 | 350 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2006 | 3701 | 0.030 |
Why?
|
Synaptophysin | 1 | 2015 | 139 | 0.030 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2022 | 1141 | 0.030 |
Why?
|
Dyspnea | 1 | 2003 | 1347 | 0.030 |
Why?
|
HEK293 Cells | 2 | 2017 | 4281 | 0.030 |
Why?
|
Morphine Dependence | 1 | 1995 | 27 | 0.030 |
Why?
|
Phosphopyruvate Hydratase | 1 | 2015 | 127 | 0.030 |
Why?
|
Solubility | 1 | 2017 | 1091 | 0.030 |
Why?
|
Immobilization | 1 | 1996 | 229 | 0.030 |
Why?
|
Neurogenesis | 1 | 2022 | 863 | 0.030 |
Why?
|
Drosophila Proteins | 1 | 2004 | 1699 | 0.030 |
Why?
|
Administration, Oral | 1 | 2003 | 4021 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2022 | 1787 | 0.030 |
Why?
|
Eating | 1 | 2021 | 1539 | 0.030 |
Why?
|
Reaction Time | 3 | 2001 | 2089 | 0.030 |
Why?
|
Quinolizines | 1 | 2014 | 20 | 0.030 |
Why?
|
Acetylation | 1 | 2017 | 1055 | 0.030 |
Why?
|
Azocines | 1 | 2014 | 20 | 0.030 |
Why?
|
Quantitative Trait, Heritable | 1 | 1997 | 543 | 0.030 |
Why?
|
Chromosomes | 1 | 1997 | 578 | 0.030 |
Why?
|
Phenotype | 3 | 2021 | 16592 | 0.030 |
Why?
|
Excitatory Postsynaptic Potentials | 1 | 2015 | 369 | 0.030 |
Why?
|
Tumor Suppressor Proteins | 1 | 2024 | 2805 | 0.030 |
Why?
|
Gene Deletion | 1 | 2021 | 2665 | 0.030 |
Why?
|
Learning | 2 | 2019 | 1740 | 0.030 |
Why?
|
Anilides | 1 | 2016 | 411 | 0.030 |
Why?
|
Alkaloids | 1 | 2014 | 192 | 0.030 |
Why?
|
Desipramine | 1 | 2013 | 182 | 0.030 |
Why?
|
Urinary Bladder | 1 | 2019 | 1152 | 0.030 |
Why?
|
Carbon Monoxide | 1 | 1996 | 547 | 0.030 |
Why?
|
Calcium-Binding Proteins | 1 | 2017 | 1069 | 0.030 |
Why?
|
Temperature | 1 | 2019 | 2226 | 0.030 |
Why?
|
Cell Line | 3 | 2012 | 15601 | 0.030 |
Why?
|
Microfilament Proteins | 1 | 2017 | 1134 | 0.020 |
Why?
|
Ether-A-Go-Go Potassium Channels | 1 | 2012 | 72 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2020 | 1974 | 0.020 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2017 | 1241 | 0.020 |
Why?
|
Receptors, Neurotransmitter | 1 | 2011 | 174 | 0.020 |
Why?
|
Protein Isoforms | 2 | 2009 | 1699 | 0.020 |
Why?
|
Neural Pathways | 1 | 2002 | 3060 | 0.020 |
Why?
|
Genetic Markers | 1 | 1997 | 2601 | 0.020 |
Why?
|
Health Status | 1 | 2004 | 4077 | 0.020 |
Why?
|
Mutation | 3 | 2024 | 30053 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2004 | 11076 | 0.020 |
Why?
|
Neuroprotective Agents | 1 | 2017 | 957 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2017 | 1363 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2022 | 2882 | 0.020 |
Why?
|
Molecular Conformation | 1 | 2012 | 544 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2016 | 934 | 0.020 |
Why?
|
Light | 1 | 2016 | 1353 | 0.020 |
Why?
|
DNA | 1 | 2023 | 7213 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2017 | 2206 | 0.020 |
Why?
|
Astrocytes | 1 | 2017 | 1346 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2018 | 2571 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2022 | 3549 | 0.020 |
Why?
|
Monoamine Oxidase Inhibitors | 1 | 2009 | 156 | 0.020 |
Why?
|
Discrimination Learning | 1 | 2010 | 278 | 0.020 |
Why?
|
Cricetulus | 1 | 2010 | 814 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 2015 | 1301 | 0.020 |
Why?
|
Prosencephalon | 1 | 2010 | 305 | 0.020 |
Why?
|
Age Factors | 3 | 2015 | 18399 | 0.020 |
Why?
|
Gene Expression | 1 | 2021 | 7581 | 0.020 |
Why?
|
Treatment Failure | 1 | 2014 | 2643 | 0.020 |
Why?
|
Dyskinesia, Drug-Induced | 1 | 2009 | 165 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2020 | 4544 | 0.020 |
Why?
|
Receptors, Opioid, mu | 1 | 2009 | 167 | 0.020 |
Why?
|
Chlordiazepoxide | 1 | 2007 | 42 | 0.020 |
Why?
|
Crystallography, X-Ray | 1 | 2012 | 1990 | 0.020 |
Why?
|
Histones | 1 | 2017 | 2580 | 0.020 |
Why?
|
Cricetinae | 1 | 2010 | 2423 | 0.020 |
Why?
|
Antigens, CD | 1 | 2017 | 4001 | 0.020 |
Why?
|
Mood Disorders | 1 | 2013 | 1127 | 0.020 |
Why?
|
Receptors, Dopamine D2 | 1 | 2009 | 485 | 0.020 |
Why?
|
Excitatory Amino Acid Agonists | 1 | 2006 | 144 | 0.020 |
Why?
|
Amphetamine | 1 | 2007 | 224 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2017 | 5790 | 0.020 |
Why?
|
Piperazines | 1 | 2016 | 2523 | 0.020 |
Why?
|
Risk | 1 | 2017 | 9610 | 0.020 |
Why?
|
Mice, Neurologic Mutants | 1 | 2005 | 107 | 0.020 |
Why?
|
Receptors, AMPA | 1 | 2006 | 336 | 0.020 |
Why?
|
Genetic Variation | 1 | 2000 | 6567 | 0.020 |
Why?
|
Analgesics, Opioid | 1 | 2001 | 3808 | 0.010 |
Why?
|
Bankruptcy | 1 | 2004 | 26 | 0.010 |
Why?
|
Pimozide | 1 | 2004 | 21 | 0.010 |
Why?
|
Patch-Clamp Techniques | 1 | 2006 | 927 | 0.010 |
Why?
|
Social Environment | 2 | 2000 | 1020 | 0.010 |
Why?
|
Membrane Potentials | 1 | 2006 | 1090 | 0.010 |
Why?
|
Cotinine | 1 | 2004 | 206 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2014 | 2811 | 0.010 |
Why?
|
Tetracycline | 1 | 2003 | 216 | 0.010 |
Why?
|
Dendrites | 1 | 2005 | 475 | 0.010 |
Why?
|
Pentylenetetrazole | 1 | 2002 | 71 | 0.010 |
Why?
|
Cytokines | 1 | 2017 | 7396 | 0.010 |
Why?
|
Pyridinium Compounds | 1 | 2002 | 81 | 0.010 |
Why?
|
GABA Antagonists | 1 | 2002 | 120 | 0.010 |
Why?
|
Reward | 1 | 2009 | 971 | 0.010 |
Why?
|
Stress, Psychological | 1 | 1997 | 4481 | 0.010 |
Why?
|
3,4-Dihydroxyphenylacetic Acid | 1 | 2001 | 63 | 0.010 |
Why?
|
Cholinergic Fibers | 1 | 2001 | 69 | 0.010 |
Why?
|
Quaternary Ammonium Compounds | 1 | 2002 | 202 | 0.010 |
Why?
|
Estrus | 1 | 2001 | 70 | 0.010 |
Why?
|
Prisoners | 1 | 2004 | 314 | 0.010 |
Why?
|
Presynaptic Terminals | 1 | 2003 | 302 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2017 | 16990 | 0.010 |
Why?
|
Clathrin | 1 | 2002 | 257 | 0.010 |
Why?
|
Transgenes | 1 | 2003 | 1010 | 0.010 |
Why?
|
Inflammation | 1 | 2019 | 10774 | 0.010 |
Why?
|
Blotting, Western | 1 | 2006 | 5035 | 0.010 |
Why?
|
Acetylcholine | 1 | 2001 | 629 | 0.010 |
Why?
|
Electrophysiology | 1 | 2001 | 1262 | 0.010 |
Why?
|
Gyrus Cinguli | 1 | 2005 | 1115 | 0.010 |
Why?
|
Age Distribution | 1 | 2004 | 2879 | 0.010 |
Why?
|
Aged | 3 | 2021 | 169310 | 0.010 |
Why?
|
Age of Onset | 1 | 2004 | 3306 | 0.010 |
Why?
|
Cell Division | 1 | 2004 | 4465 | 0.010 |
Why?
|
Interviews as Topic | 1 | 2004 | 2696 | 0.010 |
Why?
|
Cell Survival | 1 | 2006 | 5791 | 0.010 |
Why?
|
Point Mutation | 1 | 2001 | 1595 | 0.010 |
Why?
|
Glutamic Acid | 1 | 2002 | 1176 | 0.010 |
Why?
|
Species Specificity | 1 | 2000 | 2414 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2006 | 2898 | 0.010 |
Why?
|
Calcium | 1 | 2009 | 5722 | 0.010 |
Why?
|
Phosphorylation | 1 | 2006 | 8321 | 0.010 |
Why?
|
Motivation | 1 | 2004 | 2006 | 0.010 |
Why?
|
Estrogens | 1 | 2001 | 1522 | 0.010 |
Why?
|
Opioid-Related Disorders | 1 | 2009 | 2164 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2002 | 1903 | 0.010 |
Why?
|
Alcoholism | 1 | 2004 | 1973 | 0.010 |
Why?
|
Extinction, Psychological | 1 | 1996 | 371 | 0.010 |
Why?
|
Naloxone | 1 | 1995 | 370 | 0.010 |
Why?
|
Models, Neurological | 1 | 2000 | 1769 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2003 | 3612 | 0.010 |
Why?
|
Adolescent | 2 | 2013 | 88326 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2005 | 12794 | 0.010 |
Why?
|
Apoptosis | 1 | 2004 | 9490 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2013 | 58984 | 0.000 |
Why?
|
Survival Rate | 1 | 2002 | 12723 | 0.000 |
Why?
|
Young Adult | 1 | 2013 | 59260 | 0.000 |
Why?
|
Middle Aged | 2 | 2013 | 220921 | 0.000 |
Why?
|
Adult | 2 | 2013 | 221210 | 0.000 |
Why?
|
Cross-Sectional Studies | 1 | 2004 | 26129 | 0.000 |
Why?
|